BSAC Vanguard Series: the future of ADVOCACY on AMR

The COVID public health emergency has brought home how vulnerable we are to forces beyond our control. We are losing our ability to treat infectious diseases for a number of reasons, including antimicrobial resistance (AMR). AMR is a 'slow-moving' threat, which makes it harder to recognize...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of antimicrobial chemotherapy 2021-12, Vol.77 (1), p.1-2
1. Verfasser:	Osterholm, Michael T
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Communicable Diseases - drug therapy COVID-19 - drug therapy Drug Resistance, Bacterial Humans SARS-CoV-2
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!